MYLGF - Mirati Therapeutics Stock Price, News & Analysis

$6.07 0.00 (0.00 %)
(As of 11/24/2017 04:28 AM ET)
Previous Close$6.07
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume355 shs
Market Capitalization$70.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Mirati Therapeutics (OTCMKTS:MYLGF)

Mirati Therapeutics logoMethylGene, Inc. operates as a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics for cancer and infectious disease.


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:MYLGF
CUSIPN/A
WebN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Frequently Asked Questions for Mirati Therapeutics (OTCMKTS:MYLGF)

What is Mirati Therapeutics' stock symbol?

Mirati Therapeutics trades on the OTCMKTS under the ticker symbol "MYLGF."

Who are some of Mirati Therapeutics' key competitors?

Who are Mirati Therapeutics' key executives?

Mirati Therapeutics' management team includes the folowing people:

  • Martin Godbout Ph.D, Chairman of the Board (Age 57)
  • Charles M. Baum M.D., Ph.D., President, Chief Executive Officer, Director (Age 55)
  • Mark J. Gergen, Chief Operations Officer, Executive Vice President (Age 51)
  • Rachel W. Humphrey M.D., Chief Medical Officer, Executive Vice President (Age 51)
  • Jamie A. Donadio, Vice President - Finance (Age 38)
  • Henry J. Fuchs M.D., Ph.D., Independent Director (Age 55)
  • Rodney W. Lappe Ph.D., Independent Director (Age 58)
  • Peter A. Thompson M.D., Independent Director (Age 53)

How do I buy Mirati Therapeutics stock?

Shares of Mirati Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mirati Therapeutics' stock price today?

One share of Mirati Therapeutics stock can currently be purchased for approximately $6.07.

How big of a company is Mirati Therapeutics?

Mirati Therapeutics has a market capitalization of $70.20 million.


MarketBeat Community Rating for Mirati Therapeutics (MYLGF)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Mirati Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Mirati Therapeutics (OTCMKTS:MYLGF)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Mirati Therapeutics (OTCMKTS:MYLGF)

Price Target History for Mirati Therapeutics (OTCMKTS:MYLGF)

Analysts' Ratings History for Mirati Therapeutics (OTCMKTS:MYLGF)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Mirati Therapeutics (OTCMKTS:MYLGF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Mirati Therapeutics (OTCMKTS:MYLGF)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Mirati Therapeutics (OTCMKTS:MYLGF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (OTCMKTS MYLGF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Mirati Therapeutics (OTCMKTS MYLGF)

Source:
No headlines for this company have been tracked by MarketBeat.com

Social Media

Financials

Financials are not available for this stock.

Chart

Mirati Therapeutics (OTCMKTS MYLGF) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.